Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | 1,4-Dioxane | HCID 31275 | — |
| Reactant | Lithium Hexamethyldisilazide | HCID 2733832 | — |
| Reactant | 5-fluoro-1,3-dihydro-2H-indol-2-one | HCID 3731012 | — |
| Reactant | HCID 67314883 | HCID 67314883 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 67314182 | HCID 67314182 | 30% |
Reaction Steps
A solution of 5-fluoro-1,3-dihydro-indol-2-one (110 mg, 0.72 mmol) in THF (5 mL) is treated with a solution of lithium bis(trimethylsilyl)amide (1.8 mL of a 1 M solution in THF, 1.8 mmol) dropwise. The resulting solution is stirred at room temperature for 10 min. A solution of 2-(5-Hydroxy-piperidin-2-ylmethyl)-7H-furo[3,4-b]pyridin-5-one (90 mg, 0.36 mmol) in THF (2.5 mL) is added dropwise to the reaction mixture. The resulting solution is stirred for 4 h and is poured into a cold 4 M HCl solution in dioxane (4.5 mL) at 0° C. The resulting mixture is stirred at room temperature overnight. The reaction mixture is concentrated to partially remove the dioxane and is then partitioned between EtOAc and saturated aqueous NaHCO3 solution. The organic phase is collected and the aqueous phase is extracted with additional EtOAc. The combined organic extracts are dried (Na2SO4), filtered and concentrated. The residue is purified by chromatography (silica gel) MeOH-Chloroform). The product containing fractions are concentrated to give the title compound as a yellow solid (41 mg, 30%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07977351B2 |
|---|
| Source dataset | uspto-grants-2011_07 |
|---|
| ORD ID | ord-d73ed308597d44728a58299cf056d590 |
|---|
| Source note | uspto-grants-2011_07 |
|---|